Transaction Details

Footnotes

The reporting person exercised the stock options at this time due to their upcoming expiration on February 18, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to (i) cover the exercise price of the stock options and (ii) satisfy tax withholding obligations in connection with the exercise of the stock options. Dr. Kumar did not sell any shares in connection with the exercise of the options. | Right-To-Buy, pursuant to a stock option grant dated February 18, 2016. | The option vested in 36 consecutive monthly installments beginning on March 31, 2016.